Chinese Herbal Medicine as an Adjunctive Therapy Improves the Survival Rate of Patients with Ischemic Heart Disease: A Nationwide Population-Based Cohort Study
Table 2
Clinical visits for outpatient care, length of hospital stay, and medical costs for CHM and non-CHM users within 1 and 5 years after initial IHD diagnosis.
Cost
Non-CHM users
CHM users
P value§
n
Mean (IQR)
n
Mean (IQR)
1 year
Clinical visits
Outpatients care visits
19980
24 (15–38)
20186
29 (18–43)
<0.0001
Hospital length of stay (days)
8778
10 (4–29)
5925
6 (3–13)
<0.0001
Cost
Outpatients care, NTD
19980
25708 (13150–46629)
20186
25873 (14046–44315)
0.48
Hospitalization, NTD
8778
79900 (27541–206442)
5925
41225 (20837–125302)
<0.001
5 years
Clinical visits
Outpatients care visits
20001
94 (51–150)
20191
133 (86–199)
<0.0001
Hospital length of stay (days)
13230
17 (6–52)
11648
11 (4–27)
<0.001
Cost
Outpatients care (NTD)
20001
60367 (23708–128334)
20191
123496 (70499–204492)
<0.0001
Hospitalization (NTD)
13230
107436 (35341–278464)
11648
82732 (30007–212197)
<0.001
IHD: ischemic heart disease; CHM: Chinese herbal medicine; NTD: new Taiwan dollar; IQR: interquartile range.